Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 2
2001 3
2003 7
2004 4
2005 2
2006 3
2007 10
2008 11
2009 5
2010 3
2011 6
2012 7
2013 5
2014 7
2015 12
2016 13
2017 11
2018 9
2019 21
2020 14
2021 16
2022 12
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a).
Katsiki N, Vrablik M, Banach M, Gouni-Berthold I. Katsiki N, et al. Among authors: vrablik m. Pharmaceuticals (Basel). 2023 Apr 12;16(4):577. doi: 10.3390/ph16040577. Pharmaceuticals (Basel). 2023. PMID: 37111334 Free PMC article. Review.
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.
Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR; DA VINCI study. Ray KK, et al. Among authors: vrablik m. Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047. Eur J Prev Cardiol. 2021. PMID: 33580789
Lipid-lowering in diabetes: An update.
Chait A, Eckel RH, Vrablik M, Zambon A. Chait A, et al. Among authors: vrablik m. Atherosclerosis. 2023 Oct 6:117313. doi: 10.1016/j.atherosclerosis.2023.117313. Online ahead of print. Atherosclerosis. 2023. PMID: 37945448 Free article. Review.
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP).
Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner Ž, Vrablik M, Escobar C. Banach M, et al. Among authors: vrablik m. Prog Cardiovasc Dis. 2023 Jul-Aug;79:2-11. doi: 10.1016/j.pcad.2023.03.001. Epub 2023 Mar 7. Prog Cardiovasc Dis. 2023. PMID: 36889490 Free article. Review.
Statins and Inflammation.
Satny M, Hubacek JA, Vrablik M. Satny M, et al. Among authors: vrablik m. Curr Atheroscler Rep. 2021 Dec 1;23(12):80. doi: 10.1007/s11883-021-00977-6. Curr Atheroscler Rep. 2021. PMID: 34851454 Review.
Statin Intolerance in Clinical Practice.
Snejdrlova M, Altschmiedova T, Vrablik M, Stulc T, Lastuvka J, Lanska V, Ceska R. Snejdrlova M, et al. Among authors: vrablik m. Curr Atheroscler Rep. 2020 Jun 3;22(7):27. doi: 10.1007/s11883-020-00845-9. Curr Atheroscler Rep. 2020. PMID: 32495058 Review.
[Lipoprotein (a)].
Zlatohlávek L, Zídková K, Vrablík M. Zlatohlávek L, et al. Among authors: vrablik m. Vnitr Lek. 2007 Apr;53(4):434-40. Vnitr Lek. 2007. PMID: 17578180 Review. Czech.
Genetics of Familial Hypercholesterolemia: New Insights.
Vrablik M, Tichý L, Freiberger T, Blaha V, Satny M, Hubacek JA. Vrablik M, et al. Front Genet. 2020 Oct 7;11:574474. doi: 10.3389/fgene.2020.574474. eCollection 2020. Front Genet. 2020. PMID: 33133164 Free PMC article. Review.
[Statin pharmacokinetics].
Hubácek JA, Adámková V, Zídková K, Ceska R, Zlatohlávek L, Stulc T, Horínek A, Vrablík M. Hubácek JA, et al. Among authors: vrablik m. Vnitr Lek. 2008 Jan;54(1):62-7. Vnitr Lek. 2008. PMID: 18390119 Review. Czech.
188 results